Insulin Delivery Devices Market Growth Forecast through 2032 Revenue Expansion

Insulin delivery devices manufacturers are set to benefit from rising therapy adoption and device innovation, with market value projected at $67.2 billion and an estimated 7.9% annual growth rate. Shifts in care settings and reimbursement structures further consolidate long-term revenue visibility across regions.